CrestOptics S.p.A. is a leading company in the development and manufacturing of advanced systems for fluorescence microscopy that has now been acquired by Evident. Thanks to its strength in R&D and engineering, they specialize in supporting the research community, biotech, and pharma industry with custom solutions tailored for ever-changing demands, paying special attention to customers’ needs and scientific applications. Founded in 2011 with a mission to make high-end microscopy technology accessible, the company quickly achieved the necessary expertise to build top-tier systems that are indispensable for ground-breaking biological research. In November 2021 Apposite Capital, a specialist international healthcare and life science investor, acquired a majority shareholding in CrestOptics to partner with the management team and employees to accelerate market penetration globally and launch new products. CrestOptics' products are supported globally by an experienced network of distributors of our branded products and integrated into prestigious and highly complex equipment, through OEM custom design or as a component.